🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
30.20
-2.34 (-7.19%)
Nov 20, 2026, 4:00 PM EST - Market closed

Nektar Therapeutics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$153 → $149
BuyReiterates$153 → $149+393.38%Nov 16, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$185
BuyMaintains$185+512.58%Nov 16, 2026
Leerink Partners
Leerink Partners
Buy
Reiterates
$130
BuyReiterates$130+330.46%Nov 13, 2026
Wedbush
Wedbush
Hold
Maintains
$50 → $40
HoldMaintains$50 → $40+32.45%Nov 13, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$192
BuyMaintains$192+535.76%Nov 13, 2026
Unknown Analyst
Oppenheimer
No rating
Oppenheimer
Buy
Maintains
$140
BuyMaintains$140+363.58%Nov 13, 2026
UBS
UBS
Hold
Initiates
$53
HoldInitiates$53+75.50%Oct 12, 2026
BTIG
BTIG
Buy
Maintains
$178
BuyMaintains$178+489.40%Oct 9, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.